DK2988750T3 - Anvendelse af landiololhydrochlorid til langtidsbehandling af takyarytmier - Google Patents

Anvendelse af landiololhydrochlorid til langtidsbehandling af takyarytmier Download PDF

Info

Publication number
DK2988750T3
DK2988750T3 DK14720107.3T DK14720107T DK2988750T3 DK 2988750 T3 DK2988750 T3 DK 2988750T3 DK 14720107 T DK14720107 T DK 14720107T DK 2988750 T3 DK2988750 T3 DK 2988750T3
Authority
DK
Denmark
Prior art keywords
tachyarrhythmias
long
term treatment
landiolol hydrochloride
landiolol
Prior art date
Application number
DK14720107.3T
Other languages
Danish (da)
English (en)
Inventor
Günther Krumpl
Original Assignee
Aop Orphan Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48226997&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2988750(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aop Orphan Pharmaceuticals Gmbh filed Critical Aop Orphan Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK2988750T3 publication Critical patent/DK2988750T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK14720107.3T 2013-04-26 2014-04-25 Anvendelse af landiololhydrochlorid til langtidsbehandling af takyarytmier DK2988750T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165582.1A EP2796139A1 (en) 2013-04-26 2013-04-26 Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
PCT/EP2014/058456 WO2014174076A1 (en) 2013-04-26 2014-04-25 Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias

Publications (1)

Publication Number Publication Date
DK2988750T3 true DK2988750T3 (da) 2022-04-04

Family

ID=48226997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14720107.3T DK2988750T3 (da) 2013-04-26 2014-04-25 Anvendelse af landiololhydrochlorid til langtidsbehandling af takyarytmier

Country Status (28)

Country Link
US (1) US10722516B2 (es)
EP (2) EP2796139A1 (es)
JP (1) JP2016517860A (es)
KR (1) KR102268161B1 (es)
CN (1) CN105324118A (es)
AU (1) AU2014259352B2 (es)
BR (1) BR112015027051A2 (es)
CA (1) CA2910066C (es)
CL (1) CL2015003145A1 (es)
DK (1) DK2988750T3 (es)
EA (1) EA030589B1 (es)
ES (1) ES2906551T3 (es)
HK (1) HK1214511A1 (es)
HR (1) HRP20220470T1 (es)
HU (1) HUE058189T2 (es)
IL (1) IL242220B (es)
LT (1) LT2988750T (es)
MX (1) MX2015014939A (es)
NZ (1) NZ713295A (es)
PH (1) PH12015502465A1 (es)
PL (1) PL2988750T3 (es)
PT (1) PT2988750T (es)
SG (1) SG11201508824RA (es)
SI (1) SI2988750T1 (es)
TN (1) TN2015000480A1 (es)
UA (1) UA117243C2 (es)
WO (1) WO2014174076A1 (es)
ZA (1) ZA201508050B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2796139A1 (en) 2013-04-26 2014-10-29 AOP Orphan Pharmaceuticals AG Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
CN114031601B (zh) * 2022-01-12 2022-03-18 南京桦冠生物技术有限公司 一种盐酸兰地洛尔的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004323370A (ja) 2003-04-22 2004-11-18 Ono Pharmaceut Co Ltd 麻酔薬と塩酸ランジオロールとを組み合わせてなる併用剤
JP4816083B2 (ja) 2003-08-08 2011-11-16 小野薬品工業株式会社 短時間型β遮断薬を有効成分とする心拍数減少剤
JP4784037B2 (ja) 2003-08-27 2011-09-28 独立行政法人国立がん研究センター 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
CN1827109A (zh) 2006-04-14 2006-09-06 北京润德康医药技术有限公司 一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备工艺
DK2234614T3 (da) * 2007-12-21 2013-02-11 Aop Orphan Pharmaceuticals Ag Farmaceutisk sammensætning til parenteral administration af et ultrakort virkende beta-receptorblokerende middel
CN101732319B (zh) 2008-11-26 2012-11-07 天津市汉康医药生物技术有限公司 含有盐酸兰地洛尔活性成分的注射用药物组合物及其制备方法
CN102232930B (zh) 2010-05-06 2013-03-27 南京海辰药业有限公司 盐酸兰地洛尔药物组合物及其制备方法
JP2010248263A (ja) 2010-08-04 2010-11-04 National Cancer Center 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
CN102475706A (zh) 2010-11-28 2012-05-30 天津市汉康医药生物技术有限公司 一种供注射用盐酸兰地洛尔药物组合物及其制备方法
EP2796139A1 (en) 2013-04-26 2014-10-29 AOP Orphan Pharmaceuticals AG Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias

Also Published As

Publication number Publication date
PH12015502465A1 (en) 2016-02-22
MX2015014939A (es) 2016-01-12
NZ713295A (en) 2020-08-28
CL2015003145A1 (es) 2016-06-24
JP2016517860A (ja) 2016-06-20
BR112015027051A2 (pt) 2020-03-10
EA201592058A1 (ru) 2016-03-31
HK1214511A1 (zh) 2016-07-29
KR20160020411A (ko) 2016-02-23
UA117243C2 (uk) 2018-07-10
WO2014174076A1 (en) 2014-10-30
PT2988750T (pt) 2022-03-01
IL242220A0 (en) 2015-11-30
KR102268161B1 (ko) 2021-06-23
LT2988750T (lt) 2022-05-10
CN105324118A (zh) 2016-02-10
US20160074411A1 (en) 2016-03-17
CA2910066A1 (en) 2014-10-30
US10722516B2 (en) 2020-07-28
AU2014259352B2 (en) 2017-03-02
SI2988750T1 (sl) 2022-05-31
ZA201508050B (en) 2017-11-29
AU2014259352A1 (en) 2015-11-05
CA2910066C (en) 2021-10-19
EA030589B1 (ru) 2018-08-31
SG11201508824RA (en) 2015-11-27
EP2988750B1 (en) 2022-01-19
HRP20220470T1 (hr) 2022-05-27
EP2796139A1 (en) 2014-10-29
EP2988750A1 (en) 2016-03-02
ES2906551T3 (es) 2022-04-19
HUE058189T2 (hu) 2022-07-28
PL2988750T3 (pl) 2022-05-16
IL242220B (en) 2020-07-30
TN2015000480A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK3057628T3 (da) Injektionsindretning til terapeutisk middel
DK2970205T3 (da) JAK2- og ALK2-inhibitorer og fremgangsmåder til anvendelse deraf
DK3043816T3 (da) Anti-b7-h1-antistoffer til behandling af tumorer
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
DK3035926T3 (da) Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
DK2968208T3 (da) Behandling af kataplexi
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
AR095266A1 (es) Inhibidores de bromodominios tetraciclicos
DK2900657T3 (da) Cykliske etherpyrazol-4-yl-heterocyclyl-carboxamidforbindelser og fremgangsmåder til anvendelse
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK2968173T3 (da) Heterocykliske forbindelser og anvendelser deraf
DK3021838T3 (da) Behandling af fedme
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK2967049T3 (da) Metoder, forbindelser og sammensætninger til behandlingen af angiotensin relaterede sygdomme
DK3626270T3 (da) Behandling af kardiovaskulære sygdomme
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3248637T3 (da) Fremgangsmåde til optisk dosisafkodning
DK2767269T3 (da) Terapeutisk anordning
DK3069720T3 (da) Farmakologisk sammensætning indeholdende glutarimid-derivater og anvendelse deraf til behandling af eosinofile sygdomme
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf
DK2992104T3 (da) Fremgangsmåde til ekspression